查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1606708

数位生物製造市场：按部署、应用和最终用途划分 - 2025-2030 年全球预测

Digital Biomanufacturing Market by Deployment (Cloud, On-premises), Application (Antibodies, Cell & Gene Therapies, Proteins), End-use - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 194 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年数位生物製造市场规模为173.5亿美元，预计2024年将达到189.7亿美元，复合年增长率为9.67%，2030年将达331.2亿美元。

数位生物製造是指将数位技术融入药品、生质燃料和其他生物化学品等生物製品的生产过程中。这种整合提高了效率、精度和扩充性，缩小了传统生物技术与工业 4.0 之间的差距。对数位生物製造的需求源于对个人化医疗、永续生产技术以及生物製程快速创新的日益增长的需求，以应对全球健康挑战。其应用涵盖製药、农业、食品和饮料以及环境科学，并正在推动即时製程监控和预测分析的进步。最终用户范围从製药公司到农业和能源部门。关键成长要素包括资料分析、机器学习和自动化方面的技术进步，以及对生物技术的投资增加和政府对永续生产方法的支持。个人化医疗领域充满机会，数位生物製造可以优化客製化治疗的生产。为了利用这些机会，企业应专注于发展强大的数位基础设施并促进跨部门合作。然而，这个市场面临着挑战​​，包括技术实施的初始成本高昂、资料隐私问题以及生物技术和数位技术方面缺乏熟练人才。透过有针对性的人才发展和策略伙伴关係关係来解决这些限制至关重要。创新的关键领域包括使用人工智慧的生物製程优化、使用物联网的生物製造工作流程以及提高生物技术供应链透明度的区块链。研究和开发应侧重于降低营运成本并提高产品产量比率和品质。市场的本质是动态和竞争的，快速的技术进步正在不断重塑行业标准。相关人员必须保持敏捷，适应监管环境和技术创新的变化，以在不断变化的环境中保持成长和竞争力。

主要市场统计
基准年[2023] 173.5亿美元
预计年份 [2024] 189.7亿美元
预测年份 [2030] 331.2亿美元
复合年增长率（%） 9.67%

市场动态：揭示快速发展的数位生物製造市场的关键市场洞察

数位生物製造市场正在因供需的动态相互作用而转变。了解这些不断变化的市场动态可以帮助企业做出明智的投资决策、策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 数位生物製造製程的重要应用
    • 对生技药品的需求不断增加以及加强生物製造过程的必要性
    • 扩大生物製造设施运营
  • 市场限制因素
    • 部署数位生物製造技术需要高额的成本
  • 市场机会
    • 巨量资料数位双胞胎在生物製造中的新作用
    • 增加政府对智慧工厂发展的措施和投资
  • 市场挑战
    • 与数位生物製造相关的迁移和网路安全挑战

波特五力战略工具引领数位生物製造市场

波特的五力架构是了解数位生物製造市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解数位生物製造市场的外部影响

外部宏观环境因素在塑造数位生物製造市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解数位生物製造市场的竞争状况

数位生物製造市场的详细市场占有率分析可以对供应商绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV定位矩阵数位生物製造市场供应商绩效评估

FPNV定位矩阵是评估数位生物製造市场供应商的重要工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议绘製数位生物製造市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，数位生物製造市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：全面分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5.产品开发与创新：重点关注可望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 数位生物製造製程的重要应用
      • 对生技药品的需求不断增加以及加强生物製造过程的必要性
      • 扩大生物製造设施运营
    • 抑制因素
      • 引进数位生物製造技术成本高昂
    • 机会
      • 巨量资料数位双胞胎在生物製造中的新作用
      • 增加政府对智慧工厂发展的承诺与投资
    • 任务
      • 与数位生物製造相关的迁移和网路安全挑战
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章数位生物製造市场：依发展划分

  • 云
  • 本地

第七章数位生物製造市场：依应用分类

  • 抗体
  • 细胞/基因治疗
  • 蛋白质
  • 疫苗

第八章数位生物製造市场：依最终用途分类

  • 学术研究所
  • 生物製药公司
  • 合约调查机构

第九章美洲数位生物製造市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十章亚太地区数位化生物製造市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章欧洲、中东和非洲数位生物製造市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • 3M Company
  • ABB Ltd.
  • Agilent Technologies, Inc.
  • bioMerieux SA
  • Bota Biosciences, Ltd.
  • CellPort Software
  • Culture Biosciences, Inc.
  • Cytiva（Global Life Sciences Solutions USA LLC）
  • Debut Biotechnology
  • Donaldson Company, Inc.
  • Emerson Electric Co.
  • FabricNano
  • GE Healthcare
  • Indegene Limited
  • OVO Biomanufacturing
  • Samsung Biologics
  • Sanofi SA
  • Sartorius AG
  • Shimadzu Corp.
  • Siemens AG
  • Thermo Fisher Scientific Inc.
  • Waters Corp.
  • 64xBio
Product Code: MRR-5C6F41F5AF44

The Digital Biomanufacturing Market was valued at USD 17.35 billion in 2023, expected to reach USD 18.97 billion in 2024, and is projected to grow at a CAGR of 9.67%, to USD 33.12 billion by 2030.

Digital biomanufacturing refers to the integration of digital technologies into the production processes of biological products, such as pharmaceuticals, biofuels, and other biochemicals. This integration enhances efficiency, precision, and scalability, bridging the gap between traditional biotechnology and Industry 4.0. The necessity for digital biomanufacturing arises from the growing demand for personalized medicine, sustainable production techniques, and the need for rapid innovation in bioprocessing to meet global health challenges. Its applications are vast, encompassing pharmaceuticals, agriculture, food and beverage, and environmental sciences, facilitating advancements like real-time process monitoring and predictive analytics. Ultimate end-users are diverse, ranging from pharmaceutical companies to agricultural and energy sectors. Key growth factors include technological advancements in data analytics, machine learning, and automation, as well as increased investments in biotechnology and governmental support for sustainable production methods. Opportunities abound in personalized medicine, where digital biomanufacturing can optimize production for tailored therapies. Companies should focus on developing robust digital infrastructures and fostering collaborations across sectors to capitalize on these opportunities. However, the market faces challenges such as high initial costs of technology implementation, data privacy concerns, and a shortage of skilled personnel competent in both biotechnology and digital technologies. Addressing these limitations through targeted workforce development and strategic partnerships will be crucial. Critical areas for innovation include artificial intelligence-driven bioprocess optimization, IoT-based biomanufacturing workflows, and blockchain for supply chain transparency in biotech. Research and development should focus on reducing operational costs and enhancing product yield and quality. The nature of the market is dynamic and highly competitive, with rapid technological advancements continually reshaping industry standards. Stakeholders must remain agile, adapting to both regulatory changes and technological innovations to sustain growth and competitiveness in this evolving landscape.

KEY MARKET STATISTICS
Base Year [2023] USD 17.35 billion
Estimated Year [2024] USD 18.97 billion
Forecast Year [2030] USD 33.12 billion
CAGR (%) 9.67%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Digital Biomanufacturing Market

The Digital Biomanufacturing Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Significant applications of the digital biomanufacturing process
    • Increased demand for biologics and need for enhanced biomanufacturing process
    • Expanding operations of biomanufacturing facilities
  • Market Restraints
    • High costs required for the deployment of digital biomanufacturing technologies
  • Market Opportunities
    • Emerging roles of big data and digital twin in biomanufacturing
    • Growing government initiatives and investments in smart factory development
  • Market Challenges
    • Transition and cybersecurity challenges associated with digital biomanufacturing

Porter's Five Forces: A Strategic Tool for Navigating the Digital Biomanufacturing Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Digital Biomanufacturing Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Digital Biomanufacturing Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Digital Biomanufacturing Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Digital Biomanufacturing Market

A detailed market share analysis in the Digital Biomanufacturing Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Digital Biomanufacturing Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Digital Biomanufacturing Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Digital Biomanufacturing Market

A strategic analysis of the Digital Biomanufacturing Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Digital Biomanufacturing Market, highlighting leading vendors and their innovative profiles. These include 3M Company, ABB Ltd., Agilent Technologies, Inc., bioMerieux SA, Bota Biosciences, Ltd., CellPort Software, Culture Biosciences, Inc., Cytiva (Global Life Sciences Solutions USA LLC), Debut Biotechnology, Donaldson Company, Inc., Emerson Electric Co., FabricNano, GE Healthcare, Indegene Limited, OVO Biomanufacturing, Samsung Biologics, Sanofi SA, Sartorius AG, Shimadzu Corp., Siemens AG, Thermo Fisher Scientific Inc., Waters Corp., and 64xBio.

Market Segmentation & Coverage

This research report categorizes the Digital Biomanufacturing Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Deployment, market is studied across Cloud and On-premises.
  • Based on Application, market is studied across Antibodies, Cell & Gene Therapies, Proteins, and Vaccines.
  • Based on End-use, market is studied across Academic & Research Institutes, Biopharmaceutical Companies, and Contract Research Organizations.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Significant applications of the digital biomanufacturing process
      • 5.1.1.2. Increased demand for biologics and need for enhanced biomanufacturing process
      • 5.1.1.3. Expanding operations of biomanufacturing facilities
    • 5.1.2. Restraints
      • 5.1.2.1. High costs required for the deployment of digital biomanufacturing technologies
    • 5.1.3. Opportunities
      • 5.1.3.1. Emerging roles of big data and digital twin in biomanufacturing
      • 5.1.3.2. Growing government initiatives and investments in smart factory development
    • 5.1.4. Challenges
      • 5.1.4.1. Transition and cybersecurity challenges associated with digital biomanufacturing
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Digital Biomanufacturing Market, by Deployment

  • 6.1. Introduction
  • 6.2. Cloud
  • 6.3. On-premises

7. Digital Biomanufacturing Market, by Application

  • 7.1. Introduction
  • 7.2. Antibodies
  • 7.3. Cell & Gene Therapies
  • 7.4. Proteins
  • 7.5. Vaccines

8. Digital Biomanufacturing Market, by End-use

  • 8.1. Introduction
  • 8.2. Academic & Research Institutes
  • 8.3. Biopharmaceutical Companies
  • 8.4. Contract Research Organizations

9. Americas Digital Biomanufacturing Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Digital Biomanufacturing Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Digital Biomanufacturing Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. 3M Company
  • 2. ABB Ltd.
  • 3. Agilent Technologies, Inc.
  • 4. bioMerieux SA
  • 5. Bota Biosciences, Ltd.
  • 6. CellPort Software
  • 7. Culture Biosciences, Inc.
  • 8. Cytiva (Global Life Sciences Solutions USA LLC)
  • 9. Debut Biotechnology
  • 10. Donaldson Company, Inc.
  • 11. Emerson Electric Co.
  • 12. FabricNano
  • 13. GE Healthcare
  • 14. Indegene Limited
  • 15. OVO Biomanufacturing
  • 16. Samsung Biologics
  • 17. Sanofi SA
  • 18. Sartorius AG
  • 19. Shimadzu Corp.
  • 20. Siemens AG
  • 21. Thermo Fisher Scientific Inc.
  • 22. Waters Corp.
  • 23. 64xBio

LIST OF FIGURES

  • FIGURE 1. DIGITAL BIOMANUFACTURING MARKET RESEARCH PROCESS
  • FIGURE 2. DIGITAL BIOMANUFACTURING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY DEPLOYMENT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY DEPLOYMENT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS DIGITAL BIOMANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS DIGITAL BIOMANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES DIGITAL BIOMANUFACTURING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES DIGITAL BIOMANUFACTURING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC DIGITAL BIOMANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC DIGITAL BIOMANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA DIGITAL BIOMANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA DIGITAL BIOMANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. DIGITAL BIOMANUFACTURING MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. DIGITAL BIOMANUFACTURING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. DIGITAL BIOMANUFACTURING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. DIGITAL BIOMANUFACTURING MARKET DYNAMICS
  • TABLE 7. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY CLOUD, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY ON-PREMISES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY ANTIBODIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY CELL & GENE THERAPIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY PROTEINS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY VACCINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL DIGITAL BIOMANUFACTURING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS DIGITAL BIOMANUFACTURING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS DIGITAL BIOMANUFACTURING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS DIGITAL BIOMANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA DIGITAL BIOMANUFACTURING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA DIGITAL BIOMANUFACTURING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 26. BRAZIL DIGITAL BIOMANUFACTURING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 27. BRAZIL DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 28. BRAZIL DIGITAL BIOMANUFACTURING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 29. CANADA DIGITAL BIOMANUFACTURING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 30. CANADA DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 31. CANADA DIGITAL BIOMANUFACTURING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 32. MEXICO DIGITAL BIOMANUFACTURING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 33. MEXICO DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 34. MEXICO DIGITAL BIOMANUFACTURING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 35. UNITED STATES DIGITAL BIOMANUFACTURING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES DIGITAL BIOMANUFACTURING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 38. UNITED STATES DIGITAL BIOMANUFACTURING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC DIGITAL BIOMANUFACTURING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC DIGITAL BIOMANUFACTURING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 42. ASIA-PACIFIC DIGITAL BIOMANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 43. AUSTRALIA DIGITAL BIOMANUFACTURING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 44. AUSTRALIA DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 45. AUSTRALIA DIGITAL BIOMANUFACTURING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 46. CHINA DIGITAL BIOMANUFACTURING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 47. CHINA DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 48. CHINA DIGITAL BIOMANUFACTURING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 49. INDIA DIGITAL BIOMANUFACTURING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 50. INDIA DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 51. INDIA DIGITAL BIOMANUFACTURING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 52. INDONESIA DIGITAL BIOMANUFACTURING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 53. INDONESIA DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 54. INDONESIA DIGITAL BIOMANUFACTURING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 55. JAPAN DIGITAL BIOMANUFACTURING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 56. JAPAN DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. JAPAN DIGITAL BIOMANUFACTURING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 58. MALAYSIA DIGITAL BIOMANUFACTURING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 59. MALAYSIA DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 60. MALAYSIA DIGITAL BIOMANUFACTURING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 61. PHILIPPINES DIGITAL BIOMANUFACTURING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 62. PHILIPPINES DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 63. PHILIPPINES DIGITAL BIOMANUFACTURING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 64. SINGAPORE DIGITAL BIOMANUFACTURING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 65. SINGAPORE DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. SINGAPORE DIGITAL BIOMANUFACTURING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 67. SOUTH KOREA DIGITAL BIOMANUFACTURING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 68. SOUTH KOREA DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. SOUTH KOREA DIGITAL BIOMANUFACTURING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 70. TAIWAN DIGITAL BIOMANUFACTURING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 71. TAIWAN DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 72. TAIWAN DIGITAL BIOMANUFACTURING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 73. THAILAND DIGITAL BIOMANUFACTURING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 74. THAILAND DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 75. THAILAND DIGITAL BIOMANUFACTURING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 76. VIETNAM DIGITAL BIOMANUFACTURING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 77. VIETNAM DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 78. VIETNAM DIGITAL BIOMANUFACTURING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA DIGITAL BIOMANUFACTURING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA DIGITAL BIOMANUFACTURING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA DIGITAL BIOMANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 83. DENMARK DIGITAL BIOMANUFACTURING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 84. DENMARK DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 85. DENMARK DIGITAL BIOMANUFACTURING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 86. EGYPT DIGITAL BIOMANUFACTURING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 87. EGYPT DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 88. EGYPT DIGITAL BIOMANUFACTURING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 89. FINLAND DIGITAL BIOMANUFACTURING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 90. FINLAND DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 91. FINLAND DIGITAL BIOMANUFACTURING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 92. FRANCE DIGITAL BIOMANUFACTURING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 93. FRANCE DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. FRANCE DIGITAL BIOMANUFACTURING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 95. GERMANY DIGITAL BIOMANUFACTURING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 96. GERMANY DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. GERMANY DIGITAL BIOMANUFACTURING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 98. ISRAEL DIGITAL BIOMANUFACTURING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 99. ISRAEL DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 100. ISRAEL DIGITAL BIOMANUFACTURING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 101. ITALY DIGITAL BIOMANUFACTURING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 102. ITALY DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 103. ITALY DIGITAL BIOMANUFACTURING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 104. NETHERLANDS DIGITAL BIOMANUFACTURING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 105. NETHERLANDS DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 106. NETHERLANDS DIGITAL BIOMANUFACTURING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 107. NIGERIA DIGITAL BIOMANUFACTURING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 108. NIGERIA DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 109. NIGERIA DIGITAL BIOMANUFACTURING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 110. NORWAY DIGITAL BIOMANUFACTURING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 111. NORWAY DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 112. NORWAY DIGITAL BIOMANUFACTURING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 113. POLAND DIGITAL BIOMANUFACTURING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 114. POLAND DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 115. POLAND DIGITAL BIOMANUFACTURING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 116. QATAR DIGITAL BIOMANUFACTURING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 117. QATAR DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 118. QATAR DIGITAL BIOMANUFACTURING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 119. RUSSIA DIGITAL BIOMANUFACTURING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 120. RUSSIA DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 121. RUSSIA DIGITAL BIOMANUFACTURING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 122. SAUDI ARABIA DIGITAL BIOMANUFACTURING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 123. SAUDI ARABIA DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 124. SAUDI ARABIA DIGITAL BIOMANUFACTURING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH AFRICA DIGITAL BIOMANUFACTURING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH AFRICA DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH AFRICA DIGITAL BIOMANUFACTURING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 128. SPAIN DIGITAL BIOMANUFACTURING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 129. SPAIN DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 130. SPAIN DIGITAL BIOMANUFACTURING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 131. SWEDEN DIGITAL BIOMANUFACTURING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 132. SWEDEN DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 133. SWEDEN DIGITAL BIOMANUFACTURING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 134. SWITZERLAND DIGITAL BIOMANUFACTURING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 135. SWITZERLAND DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 136. SWITZERLAND DIGITAL BIOMANUFACTURING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 137. TURKEY DIGITAL BIOMANUFACTURING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 138. TURKEY DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 139. TURKEY DIGITAL BIOMANUFACTURING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED ARAB EMIRATES DIGITAL BIOMANUFACTURING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED ARAB EMIRATES DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED ARAB EMIRATES DIGITAL BIOMANUFACTURING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED KINGDOM DIGITAL BIOMANUFACTURING MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED KINGDOM DIGITAL BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED KINGDOM DIGITAL BIOMANUFACTURING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 146. DIGITAL BIOMANUFACTURING MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 147. DIGITAL BIOMANUFACTURING MARKET, FPNV POSITIONING MATRIX, 2023